Clinical Trial Update: Developing Microbials to Fight Extended-spectrum Beta-lactamase (ESBL)-Producing Escherichia Coli

View source ↗

Summary

The document reports a clinical trial update on developing microbial therapies to combat ESBL-producing Escherichia coli, noting the trial is active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Escherichia Coli Infection

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Extended Spectrum Beta Lactamases (ESBL) E. Coli | Status: ACTIVE_NOT_RECRUITING